Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
21790 | 405 | 30.8 | 70% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
12 | 4 | POLYMER SCIENCE//MATERIALS SCIENCE, PAPER & WOOD//CHEMISTRY, PHYSICAL | 1084170 |
41 | 3 | INTERNATIONAL JOURNAL OF PHARMACEUTICS//DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY//PHARMACOLOGY & PHARMACY | 99449 |
147 | 2 | SOLID LIPID NANOPARTICLES//POLYMERIC MICELLES//LIPOSOMES | 23275 |
21790 | 1 | N SUCCINYL CHITOSAN//DEXTRAN PRODRUGS//BIOPHARMACEUT DRUG METAB | 405 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | N SUCCINYL CHITOSAN | authKW | 715489 | 5% | 43% | 22 |
2 | DEXTRAN PRODRUGS | authKW | 527766 | 2% | 100% | 7 |
3 | BIOPHARMACEUT DRUG METAB | address | 431227 | 8% | 18% | 31 |
4 | LACTOSAMINATED N SUCCINYL CHITOSAN | authKW | 376976 | 1% | 100% | 5 |
5 | DRUG DELIVERY | address | 371876 | 19% | 6% | 78 |
6 | HEPATIC TARGETING | authKW | 279229 | 2% | 37% | 10 |
7 | MACROMOLECULAR CONJUGATE | authKW | 241263 | 1% | 80% | 4 |
8 | DEXTRAN METHYLPREDNISOLONE CONJUGATE | authKW | 226185 | 1% | 100% | 3 |
9 | TISSUE ISOLATED TUMOR | authKW | 226185 | 1% | 100% | 3 |
10 | 6 O CARBOXYMETHYL CHITIN | authKW | 169637 | 1% | 75% | 3 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 4418 | 60% | 0% | 244 |
2 | Chemistry, Medicinal | 754 | 13% | 0% | 54 |
3 | Chemistry, Multidisciplinary | 645 | 27% | 0% | 111 |
4 | Transplantation | 502 | 8% | 0% | 31 |
5 | Immunology | 60 | 8% | 0% | 31 |
6 | Surgery | 49 | 8% | 0% | 33 |
7 | Materials Science, Biomaterials | 44 | 2% | 0% | 8 |
8 | Oncology | 18 | 6% | 0% | 23 |
9 | Polymer Science | 8 | 3% | 0% | 12 |
10 | Multidisciplinary Sciences | 7 | 1% | 0% | 4 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BIOPHARMACEUT DRUG METAB | 431227 | 8% | 18% | 31 |
2 | DRUG DELIVERY | 371876 | 19% | 6% | 78 |
3 | BASIC PHARMACEUT | 109661 | 1% | 36% | 4 |
4 | YOSHIDA SHIMOADACHI CHO | 104708 | 1% | 28% | 5 |
5 | EXPLORAT S 523 TOKODAI | 75395 | 0% | 100% | 1 |
6 | FRONT MED SCI | 75395 | 0% | 100% | 1 |
7 | ND 20 | 75395 | 0% | 100% | 1 |
8 | ONKOLOG ZENTRUM 3 | 75395 | 0% | 100% | 1 |
9 | OPPOSITE J L NEHRU AGR | 75395 | 0% | 100% | 1 |
10 | PHAM | 75395 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF CONTROLLED RELEASE | 9111 | 7% | 0% | 30 |
2 | JOURNAL OF DRUG TARGETING | 8179 | 3% | 1% | 13 |
3 | BIOLOGICAL & PHARMACEUTICAL BULLETIN | 6378 | 7% | 0% | 27 |
4 | PHARMACEUTICAL RESEARCH | 4543 | 5% | 0% | 22 |
5 | INTERNATIONAL JOURNAL OF PHARMACEUTICS | 3978 | 7% | 0% | 29 |
6 | CHEMICAL & PHARMACEUTICAL BULLETIN | 2289 | 6% | 0% | 23 |
7 | JOURNAL OF PHARMACEUTICAL SCIENCES | 2159 | 4% | 0% | 18 |
8 | DRUG DELIVERY | 1444 | 1% | 0% | 5 |
9 | REVUE CANADIENNE DE BIOLOGIE EXPERIMENTALE | 1255 | 0% | 2% | 1 |
10 | JOURNAL OF PHARMACOBIO-DYNAMICS | 1149 | 1% | 0% | 5 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | KATO, Y , ONISHI, H , MACHIDA, Y , (2004) N-SUCCINYL-CHITOSAN AS A DRUG CARRIER: WATER-INSOLUBLE AND WATER-SOLUBLE CONJUGATES.BIOMATERIALS. VOL. 25. ISSUE 5. P. 907-915 | 26 | 59% | 81 |
2 | TAKAKURA, Y , (1996) DEVELOPMENT OF DRUG DELIVERY SYSTEMS FOR MACROMOLECULAR DRUGS.YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN. VOL. 116. ISSUE 7. P. 519 -532 | 32 | 70% | 6 |
3 | HASHIDA, M , NISHIKAWA, M , TAKAKURA, Y , (1995) HEPATIC TARGETING OF DRUGS AND PROTEINS BY CHEMICAL MODIFICATION.JOURNAL OF CONTROLLED RELEASE. VOL. 36. ISSUE 1-2. P. 99-107 | 19 | 83% | 22 |
4 | ISHIKI, N , ONISHI, H , MACHIDA, Y , (1997) BIOLOGICAL PROPERTIES OF CONJUGATES OF MITOMYCIN C WITH ESTRADIOL BENZOATE AND ESTRADIOL: THEIR STABILITY CHARACTERISTICS IN BIOLOGICAL MEDIA AND THEIR BINDING ABILITIES TO ESTROGEN RECEPTOR.BIOLOGICAL & PHARMACEUTICAL BULLETIN. VOL. 20. ISSUE 10. P. 1096 -1102 | 17 | 85% | 9 |
5 | TAKAKURA, Y , MAHATO, RI , HASHIDA, M , (1998) EXTRAVASATION OF MACROMOLECULES.ADVANCED DRUG DELIVERY REVIEWS. VOL. 34. ISSUE 1. P. 93 -108 | 29 | 43% | 78 |
6 | MEHVAR, R , (2000) DEXTRANS FOR TARGETED AND SUSTAINED DELIVERY OF THERAPEUTIC AND IMAGING AGENTS.JOURNAL OF CONTROLLED RELEASE. VOL. 69. ISSUE 1. P. 1 -25 | 33 | 29% | 230 |
7 | ZHANG, XP , MEHVAR, R , (2001) DEXTRAN-METHYLPREDNISOLONE SUCCINATE AS A PRODRUG OF METHYLPREDNISOLONE: PLASMA AND TISSUE DISPOSITION.JOURNAL OF PHARMACEUTICAL SCIENCES. VOL. 90. ISSUE 12. P. 2078-2087 | 19 | 61% | 15 |
8 | NISHIKAWA, M , TAKAKURA, Y , HASHIDA, M , (1996) PHARMACOKINETIC EVALUATION OF POLYMERIC CARRIERS.ADVANCED DRUG DELIVERY REVIEWS. VOL. 21. ISSUE 2. P. 135-155 | 36 | 35% | 45 |
9 | NISHIKAWA, M , (2005) DEVELOPMENT OF CELL-SPECIFIC TARGETING SYSTEMS FOR DRUGS AND GENES.BIOLOGICAL & PHARMACEUTICAL BULLETIN. VOL. 28. ISSUE 2. P. 195 -200 | 22 | 42% | 24 |
10 | NISHIKAWA, M , HASHIDA, M , TAKAKURA, Y , (2009) CATALASE DELIVERY FOR INHIBITING ROS-MEDIATED TISSUE INJURY AND TUMOR METASTASIS.ADVANCED DRUG DELIVERY REVIEWS. VOL. 61. ISSUE 4. P. 319-326 | 31 | 24% | 62 |
Classes with closest relation at Level 1 |